Interleukin-1 receptor type 2
| GO Term |
|---|
| cell surface |
| extracellular region |
| cytoplasm |
| plasma membrane |
| GO Term |
|---|
| interleukin-1 receptor activity |
| interleukin-1 binding |
| interleukin-1, type II, blocking receptor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 66 | N-linked (GlcNAc...) asparagine | |||
| 72 | N-linked (GlcNAc...) asparagine |
|
||
| 112 | N-linked (GlcNAc...) asparagine |
|
||
| 219 | N-linked (GlcNAc...) asparagine | |||
| 277 | N-linked (GlcNAc...) asparagine |
|
| Pathway Name | Organism |
|---|---|
| Interleukin-1 signaling | Homo sapiens |
| Interleukin-10 signaling | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050686 | organ system cancer | |
| DOID:1324 | lung cancer | |
| DOID:1474 | aggressive periodontitis | |
| DOID:5041 | esophageal cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025